Search research articles
Contact Us
Filters
Showing results (291-300 of 302) with videos related to
Page
of 31
Sort By:
Stem Cells (Dayton, Ohio)
|
April 10, 2014
Dominant role of peroxiredoxin/JNK axis in stemness regulation during neurogenesis from embryonic stem cells
Sun-Uk Kim, Young-Ho Park, Jin-Man Kim, et al.
Journal of Neurochemistry
|
March 30, 2010
Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades
Hu-Nan Sun, Sun-Uk Kim, Song Mei Huang, et al.
Science China. Life Sciences
|
June 30, 2023
A comprehensive analysis of the Bencao (herbal) small RNA Atlas reveals novel RNA therapeutics for treating human diseases
Yinghao Cao, Yexuan Lin, Na Sun, et al.
Nature Immunology
|
July 5, 2011
The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors
Jae-Min Yuk, Dong-Min Shin, Hye-Mi Lee, et al.
Signal Transduction and Targeted Therapy
|
July 28, 2025
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights
Lei Shi, Ziying Zhang, Song Mei, et al.
British Journal of Cancer
|
September 2, 2025
Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study
Fu-Sheng Liu, Ying-Yi Liu, Shi-Kun Zhang, et al.
British Journal of Cancer
|
October 21, 2025
Correction: Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study
Fu-Sheng Liu, Ying-Yi Liu, Shi-Kun Zhang, et al.
Journal of Medicinal Chemistry
|
May 27, 2026
Discovery of Dual A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Antagonist and Clinical Candidate INCB106385
Chao Qi, Matthew S McCammant, Yong Li, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies
Niu Shin, Yun-Long Li, Song Mei, et al.
Journal of Medicinal Chemistry
|
May 27, 2026
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases
Jincong Zhuo, Yun-Long Li, Ding-Quan Qian, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 302) with videos related to
Sort By:
Page
of 31
Stem Cells (Dayton, Ohio)
|
April 10, 2014
Dominant role of peroxiredoxin/JNK axis in stemness regulation during neurogenesis from embryonic stem cells
Sun-Uk Kim, Young-Ho Park, Jin-Man Kim, et al.
Journal of Neurochemistry
|
March 30, 2010
Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades
Hu-Nan Sun, Sun-Uk Kim, Song Mei Huang, et al.
Science China. Life Sciences
|
June 30, 2023
A comprehensive analysis of the Bencao (herbal) small RNA Atlas reveals novel RNA therapeutics for treating human diseases
Yinghao Cao, Yexuan Lin, Na Sun, et al.
Nature Immunology
|
July 5, 2011
The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors
Jae-Min Yuk, Dong-Min Shin, Hye-Mi Lee, et al.
Signal Transduction and Targeted Therapy
|
July 28, 2025
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights
Lei Shi, Ziying Zhang, Song Mei, et al.
British Journal of Cancer
|
September 2, 2025
Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study
Fu-Sheng Liu, Ying-Yi Liu, Shi-Kun Zhang, et al.
British Journal of Cancer
|
October 21, 2025
Correction: Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study
Fu-Sheng Liu, Ying-Yi Liu, Shi-Kun Zhang, et al.
Journal of Medicinal Chemistry
|
May 27, 2026
Discovery of Dual A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Antagonist and Clinical Candidate INCB106385
Chao Qi, Matthew S McCammant, Yong Li, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies
Niu Shin, Yun-Long Li, Song Mei, et al.
Journal of Medicinal Chemistry
|
May 27, 2026
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases
Jincong Zhuo, Yun-Long Li, Ding-Quan Qian, et al.
Page
of 31